US patent issued for protofibril-binding antibodies for treatment and diagnostics of Parkinson’s Disease, Dementia with Lewy Bodies and other Alpha-Synucleinopathies

The US patent office has granted a BioArctic patent for protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson’s Disease, Dementia with Lewy Bodies and other Alpha-Synucleinopathies.